Dorsey & Whitney Trust’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $246K | Sell |
15,897
-4,243
| -21% | -$65.6K | 0.01% | 590 |
|
|
2025
Q1 | $299K | Buy |
20,140
+4,591
| +30% | +$68.3K | 0.02% | 515 |
|
|
2024
Q4 | $206K | Sell |
15,549
-773
| -5% | -$10.2K | 0.01% | 639 |
|
|
2024
Q3 | $232K | Buy |
16,322
+452
| +3% | +$6.43K | 0.01% | 602 |
|
|
2024
Q2 | $205K | Sell |
15,870
-2,327
| -13% | -$30.1K | 0.01% | 591 |
|
|
2024
Q1 | $253K | Buy |
18,197
+798
| +5% | +$11.1K | 0.02% | 529 |
|
|
2023
Q4 | $248K | Sell |
17,399
-10,422
| -37% | -$149K | 0.02% | 508 |
|
|
2023
Q3 | $430K | Buy |
27,821
+8,406
| +43% | +$130K | 0.04% | 342 |
|
|
2023
Q2 | $305K | Sell |
19,415
-1,833
| -9% | -$28.8K | 0.03% | 432 |
|
|
2023
Q1 | $350K | Buy |
21,248
+8,304
| +64% | +$137K | 0.03% | 395 |
|
|
2022
Q4 | $202K | Sell |
12,944
-12,041
| -48% | -$188K | 0.02% | 530 |
|
|
2022
Q3 | $324K | Buy |
24,985
+13,671
| +121% | +$177K | 0.03% | 381 |
|
|
2022
Q2 | $158K | Sell |
11,314
-9,110
| -45% | -$127K | 0.02% | 514 |
|
|
2022
Q1 | $293K | Buy |
20,424
+3,086
| +18% | +$44.3K | 0.03% | 426 |
|
|
2021
Q4 | $237K | Sell |
17,338
-62
| -0.4% | -$848 | 0.02% | 482 |
|
|
2021
Q3 | $285K | Buy |
17,400
+1,670
| +11% | +$27.4K | 0.03% | 411 |
|
|
2021
Q2 | $265K | Sell |
15,730
-1,343
| -8% | -$22.6K | 0.03% | 430 |
|
|
2021
Q1 | $312K | Buy |
17,073
+2,341
| +16% | +$42.8K | 0.03% | 379 |
|
|
2020
Q4 | $268K | Sell |
14,732
-1,720
| -10% | -$31.3K | 0.03% | 379 |
|
|
2020
Q3 | $294K | Buy |
16,452
+1,842
| +13% | +$32.9K | 0.04% | 304 |
|
|
2020
Q2 | $262K | Buy |
+14,610
| New | +$262K | 0.04% | 337 |
|